Drug Trial Radar · NCT06021522
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
Last checked: Nov 19, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Aug 16, 2023
Primary completion
Feb 2028
Study completion Feb 2028
Sponsor
- Lead sponsor
- Emalex Biosciences Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to \[\>=\] 6 and less than \[\<\] 12 years of age), adolescents (\>=12 and \<18 years of age), and adults (\>=18 years of age) with Tourette's Syndrome (TS).
Conditions
- Tourette Syndrome
Interventions
EcopipamDrug
Selective dopamine D1 and D5 receptor antagonist
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline up to Month 24
Locations
67 sites in 8 countries. Site status is shown where the registry gives one.
Harmonex, Inc.
Dothan, Alabama
Arkansas Children's Hospital
Little Rock, Arkansas
Advanced Research Center
Anaheim, California
CenExel CIT-IE
Bellflower, California
Cortica Site Network
Glendale, California
Cortica Site Network - San Rafael
San Rafael, California
Yale School of Medicine
New Haven, Connecticut
Childrens National Hospital
Washington D.C., District of Columbia
NW FL Clinical Research Group, LLC
Gulf Breeze, Florida
Research in Miami Inc
Hialeah, Florida
University of Miami Miller School of Medicine
Miami, Florida
Florida International Research Center
Miami, Florida
Medical Research Group of Central Florida
Orange City, Florida
APG Research, LLC
Orlando, Florida
University of South Florida
St. Petersburg, Florida
Pediatric Epilepsy and Neurology Specialists
Tampa, Florida
Rare Disease Research, LLC
Atlanta, Georgia
Lurie Children Hospital of Chicago
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
Josephson-Wallack-Munshower Neurology
Indianapolis, Indiana
University of Louisville Research Foundation Inc.
Louisville, Kentucky
Kennedy Krieger Institute
Baltimore, Maryland
Mass General Hospital
Boston, Massachusetts
Boston Childrens Hospital
Boston, Massachusetts
Umass Chan Medical School
Worcester, Massachusetts
Michigan Clinical research Institute PC
Ann Arbor, Michigan
Neurobahavioral Medicine Group
Bloomfield Hills, Michigan
St. Louis Children's Hospital
St Louis, Missouri
Alivation Research
Lincoln, Nebraska
University of Rochester
Rochester, New York
OnSite Clinical Solutions LLC
Charlotte, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
National Childrens Hospital - The Ohio State University
Columbus, Ohio
North Star Medical Research, LLC
Middleburg Heights, Ohio
Providence Brain and Spine Institute
Portland, Oregon
Coastal Pediatric Research
Charleston, South Carolina
Access Clinical Trials, Inc.
Nashville, Tennessee
Access Clinical Trials, Inc.
Nashville, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee
UT Southwestern
Dallas, Texas
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.